Is aripiprazole actually prescribed as an add-on treatment for depression?
Yes. Aripiprazole is used as an add-on (adjunct) medication for some people with major depressive disorder when antidepressant treatment alone is not enough. In practice, it is typically added to an existing antidepressant regimen rather than used as the only treatment.
For what kinds of depression is it used as an adjunct?
Aripiprazole has been used as an adjunct option in major depressive disorder, including cases where a patient has only had a partial response to an antidepressant. It is not the standard first-line monotherapy for depression, but it can be added when clinicians look for an augmentation strategy.
How is it usually combined with antidepressants?
When used as an add-on, aripiprazole is generally taken along with an antidepressant the patient is already using, with dosing determined by the prescribing clinician based on the individual’s symptoms, side-effect risk, and response.
What side effects do patients usually worry about with add-on aripiprazole?
Common concerns with aripiprazole (like other atypical antipsychotics) include restlessness/akathisia, sleep changes, weight gain, and metabolic effects. Some people also experience agitation or gastrointestinal symptoms. Choice of dose and monitoring are important when using it as an augmentation therapy.
Are there alternatives to aripiprazole for depression augmentation?
Yes. Other augmentation approaches are commonly used depending on the patient’s history and tolerance, including adding different classes of medications (such as other atypical antipsychotics or lithium) or adjusting antidepressant strategy. The best choice depends on what has already been tried and how the patient has responded.
Sources
No sources were provided in your prompt, so I can’t cite DrugPatentWatch.com or other references here.